Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EVOK | SLGL | MGX | ||
| Company | Evoke Pharma | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.98 | 67.83 | 1.2500 | ||
| High | 11.00 | 67.83 | 1.2800 | ||
| Low | 10.98 | 62.50 | 1.2400 | ||
| Latest | 11.00 | 63.31 | 1.2500 | ||
| Change | +0.04 | -5.04 | -0.0200 | ||
| % Change | +0.36% | -7.37% | -1.57% | ||
| Volume | 47,100 | 12,500 | 120,700 | ||
| 20-Day Average Volume | 30,765 | 21,210 | 161,875 | ||
| Previous Close | 10.96 | 68.35 | 1.2700 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.86 | 71.81 | 1.3895 | ||
| 20-Day Raw Stochastic | 100.00% | 3.90% | 3.57% | ||
| 20-Day Relative Strength | 81.71 | 42.88 | 37.13 | ||
| Weighted Alpha | -6.22 | +267.22 | -36.90 | ||
| Today's Opinion | 100% Buy | 24% Buy | 100% Sell | ||
| Previous Opinion | 100% Buy | 24% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.64% since 12/09/25 | -5.80% since 05/12/26 | -7.41% since 05/12/26 | ||
| Low | 10.92 on 12/11/25 | 62.50 on 05/19/26 | 1.2400 on 05/19/26 | ||
| High | 11.00 on 12/16/25 | 74.80 on 05/13/26 | 1.3879 on 05/13/26 | ||
| 1-Month | |||||
| %Chg | +2.90% since 11/14/25 | -14.30% since 04/17/26 | -15.54% since 04/17/26 | ||
| Low | 10.66 on 11/21/25 | 62.50 on 05/19/26 | 1.2400 on 05/19/26 | ||
| High | 11.00 on 12/16/25 | 83.25 on 04/24/26 | 1.5500 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | +112.36% since 09/16/25 | -21.69% since 02/19/26 | -17.76% since 02/19/26 | ||
| Low | 4.23 on 10/03/25 | 61.92 on 03/23/26 | 1.2400 on 05/19/26 | ||
| High | 11.00 on 12/16/25 | 97.97 on 03/03/26 | 1.8250 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +274.15% since 06/16/25 | +75.67% since 11/19/25 | -22.36% since 11/19/25 | ||
| Low | 2.46 on 06/23/25 | 34.10 on 11/20/25 | 1.2400 on 05/19/26 | ||
| High | 11.00 on 12/16/25 | 97.97 on 03/03/26 | 1.8700 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,946 | 192,057 | 47,812 | ||
| Shares Outstanding, K | 1,722 | 2,810 | 37,647 | ||
| Annual Sales | 10,250,000 | 19,390,000 | 25,210,000 | ||
| Annual Net Income | -5,350,000 | -6,130,000 | -87,870,000 | ||
| Last Quarter Sales | 4,280,000 | 700,000 | 1,250,000 | ||
| Last Quarter Net Income | -1,160,000 | -2,990,000 | -23,060,000 | ||
| 60-Month Beta | -0.15 | 1.16 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 11/13/25 | -1.07 on 03/19/26 | -0.61 on 05/11/26 | ||
| Earnings Date | 03/12/26 | 05/22/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||